BioSpace News Archive

Paris-based Sanofi reported its third-quarter finances, with most of its categories showing strong growth. However, not everything was rosy

Despite these challenges, Raphael remains dedicated to developing the field of cancer metabolism-based therapeutics.

The letter was related to a 2021 FDA inspection connected to Sesen’s Biologics License Application for Vicineum. Read more about this sesen bio news here.

The life sciences industry continues to be one of the fastest growing industries in the world as the end of the year draws near.

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

Entera Bio Ltd. (NASDAQ: ENTX), today announced that researchers at the company and the University of East Anglia in the UK published preclinical in vivo studies which demonstrate the technologies efficiency in the oral delivery of large molecule biologic drugs.

Integra LifeSciences Holdings Corporation today announced that it has appointed Jan D. De Witte as its next President and Chief Executive Officer.

Alnylam Pharmaceuticals, Inc. today reported its consolidated financial results for the third quarter ended September 30, 2021 and reviewed recent business highlights.

GenesisCare — one of the leading oncology providers in the United States, Australia, Spain, and the United Kingdom — today announced it will be expanding access to the novel fluorinated prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging capabilities in its Florida, South Carolina, and Texas centers.

Viveve Medical, Inc., a medical technology company focused on women’s intimate health, announced that the United States Patent and Trademark Office recently issued U.S. Patent No. 11,154,349.